Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study

被引：0
|
作者：
Tatsuo Hosoya
Takafumi Sano
Tomomitsu Sasaki
Masahiko Fushimi
Tetsuo Ohashi
机构：
[1] Jikei University School of Medicine,Medical R&D Division, Development Department
[2] Fuji Yakuhin Co.,undefined
[3] Ltd.,undefined
来源：
Clinical and Experimental Nephrology | 2020年 / 24卷
关键词：
Hyperuricemia; Uricosuric; Selective urate reabsorption inhibitor; Dotinurad; FYU-981; Benzbromarone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：62 / 70
页数：8
相关论文
共 50 条
  • [1] Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study
    Hosoya, Tatsuo
    Sano, Takafumi
    Sasaki, Tomomitsu
    Fushimi, Masahiko
    Ohashi, Tetsuo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (SUPPL 1) : 62 - 70
  • [2] Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study
    Hosoya, T.
    Ogawa, Y.
    Hashimoto, H.
    Ohashi, T.
    Sakamoto, R.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (03) : 290 - 297
  • [3] Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study
    Hosoya, Tatsuo
    Sano, Takafumi
    Sasaki, Tomomitsu
    Fushimi, Masahiko
    Ohashi, Tetsuo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (SUPPL 1) : 53 - 61
  • [4] Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study
    Tatsuo Hosoya
    Takafumi Sano
    Tomomitsu Sasaki
    Masahiko Fushimi
    Tetsuo Ohashi
    Clinical and Experimental Nephrology, 2020, 24 : 53 - 61
  • [5] Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study
    Hosoya, Tatsuo
    Sano, Takafumi
    Sasaki, Tomomitsu
    Fushimi, Masahiko
    Ohashi, Tetsuo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (SUPPL 1) : 44 - 52
  • [6] Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study
    Tatsuo Hosoya
    Takafumi Sano
    Tomomitsu Sasaki
    Masahiko Fushimi
    Tetsuo Ohashi
    Clinical and Experimental Nephrology, 2020, 24 : 44 - 52
  • [7] A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout
    Fengchun Zhang
    Zhichun Liu
    Lindi Jiang
    Hao Zhang
    Dongbao Zhao
    Yang Li
    Hejian Zou
    Xiaoyue Wang
    Xiangpei Li
    Bingyin Shi
    Jianhua Xu
    Hongjie Yang
    Shaoxian Hu
    Shen Qu
    Rheumatology and Therapy, 2019, 6 : 543 - 557
  • [8] A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout
    Zhang, Fengchun
    Liu, Zhichun
    Jiang, Lindi
    Zhang, Hao
    Zhao, Dongbao
    Li, Yang
    Zou, Hejian
    Wang, Xiaoyue
    Li, Xiangpei
    Shi, Bingyin
    Xu, Jianhua
    Yang, Hongjie
    Hu, Shaoxian
    Qu, Shen
    RHEUMATOLOGY AND THERAPY, 2019, 6 (04) : 543 - 557
  • [9] FELODIPINE VERSUS MODURETIC - A DOUBLE-BLIND PARALLEL-GROUP MULTICENTER STUDY
    KRONIG, B
    FLYGT, G
    DRUGS, 1987, 34 : 162 - 169
  • [10] Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study
    Keary, Christopher
    Bird, Lynne M.
    de Wit, Marie-Claire
    Hatti, Shivkumar
    Heimer, Gali
    Heussler, Helen
    Kolevzon, Alexander
    Mathews, Adera
    Ochoa-Lubinoff, Cesar
    Tan, Wen-Hann
    Yan, Ying
    Adams, Maxwell
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2023, 47 : 6 - 12
12345